Cardiac Biotech Solutions Inc. (CBSC)
OTCMKTS · Delayed Price · Currency is USD
0.0350
+0.0035 (11.11%)
At close: Sep 30, 2026
Cardiac Biotech Solutions Revenue
Cardiac Biotech Solutions had revenue of $14.68K in the quarter ending March 31, 2018. This brings the company's revenue in the last twelve months to $50.37K. In the fiscal year ending March 31, 2018, Cardiac Biotech Solutions had annual revenue of $36.61K with 11.11% growth. That makes Cardiac Biotech Solutions the 46,513th largest company in the world by revenue and 6,935th in the United States.
Revenue (ttm)
50.37K
Revenue Growth
+11.11%
P/S Ratio
118.43
Revenue / Employee
10.07K
Employees
5
Market Cap
5.97M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2018 | 36.61K | 3.66K | 11.11% |
| Mar 31, 2017 | 32.95K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Cardiac Biotech Solutions News
- 1 year ago - CB Scientific, Inc. (CBSC) Announces Corporate Name Change to Cardiac Biotech Solutions, Inc. - Accesswire
- 1 year ago - CB Scientific Inc. (CBSC) Formally Launches Next Generation MyCardia AT Cardiac Monitor - Accesswire
- 2 years ago - CB Scientific, Inc. Appoints Trip Thomas as Chief Financial Officer - Accesswire
- 2 years ago - CB Scientific, Inc. Announces Voluntary Delisting from OTCQB Venture Market - Accesswire
- 2 years ago - CB Scientific, Inc. Concludes its Annual Meeting of Stockholders - Accesswire
- 2 years ago - CB Scientific, Inc. 2023 Year in Review - Accesswire
- 3 years ago - CB Scientific, Inc. Announces Exclusive Canadian Distribution Agreement - Accesswire
- 4 years ago - CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor - Accesswire